The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-12.7% to $205.00
Predicted High$255.00at 2 months
Predicted Low$205.00at 6 months
Max Drawdown (predicted)-12.7%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 8:30 pm
Bear
CRDO trends lower to
$205.00
(-12.7% from $234.82)
by Feb 2027.
ride-then-fade
ThesisCRDO is a high-beta AI-infrastructure momentum name up 97% over six months with strong quality signals but stretched valuation (attractive only below $150). In a risk-on regime with no earnings catalyst near-term, momentum likely carries it modestly higher before valuation gravity and beta-driven volatility create a pullback later in the window.
Invalidated ifA break below $200 on heavy volume, or a regime flip to risk-off, would invalidate the near-term upside leg.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $234.82 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$234.82at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$185.84–$283.80typical range · internal point $242.00
—
±20.9%
6/10
Momentum and risk-on regime extend recent uptrend
1 month
Sep 19, 2026
$163.84–$305.80typical range · internal point $248.00
—
±30.2%
5/10
AI-infra bid persists, no catalyst to break trend
2 months
Oct 19, 2026
$255.00
—
+8.6%
4/10
Peak euphoria into potential earnings window
3 months
Nov 19, 2026
$240.00
—
+2.2%
4/10
Post-earnings digestion, high-beta profit-taking
4 months
Dec 19, 2026
$225.00
—
-4.2%
4/10
Valuation gravity begins reasserting versus fair-value gap
5 months
Jan 19, 2027
$215.00
—
-8.4%
3/10
Year-end rotation away from stretched high-beta names
6 months
Feb 19, 2027
$205.00
—
-12.7%
3/10
Continued mean-reversion toward attractive-below-150 zone
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.